These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6250183)
21. On the mechanism of antidepressant-like action of berberine chloride. Kulkarni SK; Dhir A Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703 [TBL] [Abstract][Full Text] [Related]
22. The role of the beta-adrenergic system in behavior: antidepressant effects of propranolol. Korol B; Brown ML Curr Ther Res Clin Exp; 1967 May; 9(5):269-79. PubMed ID: 4963062 [No Abstract] [Full Text] [Related]
23. Membrane effects of drugs interfering with adrenergic mechanisms. Lemmer B; Hellenbrecht D; Grobecker H Acta Physiol Pol; 1973; 24(1):285-8. PubMed ID: 4123752 [No Abstract] [Full Text] [Related]
24. Monoamine receptor sensitivity and the mechanism of action of antidepressant treatment. Psychopharmacol Bull; 1982 Jul; 18(3):130-55. PubMed ID: 6292986 [No Abstract] [Full Text] [Related]
25. Acute treatment with antidepressant drugs selectively increases the expression of c-fos in the rat brain. Beck CH J Psychiatry Neurosci; 1995 Jan; 20(1):25-32. PubMed ID: 7865498 [TBL] [Abstract][Full Text] [Related]
27. Mechanisms of action of antidepressant drugs. Hamon M Adv Biosci; 1978 Jul 24-25; 21():117-28. PubMed ID: 385392 [No Abstract] [Full Text] [Related]
28. Brain noradrenergic neurons, their interactions and role in the action of antidepressive drugs. Kostowski W Acta Physiol Pharmacol Bulg; 1982; 8(1-2):29-36. PubMed ID: 7124417 [No Abstract] [Full Text] [Related]
29. Effects of lithium and antidepressant treatment on neurotransmitter receptors. International Symposium on the Neuropharmacology of Manic-Depressive Illness. Copenhagen, June 20-22, 1983. Acta Pharmacol Toxicol (Copenh); 1985; 56 Suppl 1():1-218. PubMed ID: 2984879 [No Abstract] [Full Text] [Related]
31. Effects of lithium and antidepressant treatment on neurotransmitter receptors. Introduction. Schou M Acta Pharmacol Toxicol (Copenh); 1985; 56 Suppl 1():11-4. PubMed ID: 2984880 [No Abstract] [Full Text] [Related]
32. Interaction of oxypertine with rat brain monoamine receptors. Nakahara T; Kojima M; Uchimura H; Hirano M; Kim JS; Matsumoto T Biochem Pharmacol; 1980 Oct; 29(19):2681-3. PubMed ID: 6107084 [No Abstract] [Full Text] [Related]
33. The role of the locus coeruleus-limbic noradrenergic transmission in the action of antidepressant drugs. Kostowski W; Plaźnik A; Danysz W Psychopharmacol Bull; 1986; 22(2):512-22. PubMed ID: 3022322 [No Abstract] [Full Text] [Related]
34. Report of international activities--current research in Denmark. Rafaelsen OJ Psychopharmacol Bull; 1983; 19(2):247-53. PubMed ID: 6306714 [No Abstract] [Full Text] [Related]
35. The histochemical mapping of "chemical pathways" in the central nervous system. Marsden CA Tidsskr Nor Laegeforen; 1973 Jun; 93(17):1291-4. PubMed ID: 4356433 [No Abstract] [Full Text] [Related]
36. The importance of catecholamine uptake inhibition in the reversal of guanethidine blockade of adrenergic neurons. Lee CH; Strosberg AM; Warren LA Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):3-14. PubMed ID: 7433767 [TBL] [Abstract][Full Text] [Related]
37. Studies of bupropion's mechanism of antidepressant activity. Ferris RM; Cooper BR; Maxwell RA J Clin Psychiatry; 1983 May; 44(5 Pt 2):74-8. PubMed ID: 6406468 [TBL] [Abstract][Full Text] [Related]
38. Perspectives in the molecular mechanisms of antidepressant action. Costa E Adv Biochem Psychopharmacol; 1982; 31():21-6. PubMed ID: 6123223 [No Abstract] [Full Text] [Related]